Page 348 - Avian Virology: Current Research and Future Trends
P. 348
Infectious Laryngotracheitis Virus | 339
Croville, G., Foret, C., Heuillard, P., Senet, A., Delpont, M., Mouahid, M., Fuchs, W., and Mettenleiter, T.C. (1999). DNA sequence of the
Ducatez, M.F., Kichou, F., and Guerin, J.L. (2018). Disclosing respiratory UL6 to UL20 genes of infectious laryngotracheitis virus and
co-infections: a broad-range panel assay for avian respiratory pathogens characterization of the UL10 gene product as a nonglycosylated and
on a nanofluidic PCR platform. Avian Pathol. 47, 253–260. https://doi. nonessential virion protein. J. Gen. Virol. 80, 2173–2182. https://doi.
org/10.1080/03079457.2018.1430891 org/10.1099/0022-1317-80-8-2173
Cruickshank, J.G., Berry, D.M., and Hay, B. (1963). The fine structure of Fuchs, W., and Mettenleiter, T.C. (2005). The nonessential UL49.5 gene
infectious laryngotracheitis virus. Virology 20, 376–378. of infectious laryngotracheitis virus encodes an O-glycosylated protein
Davidson, I., Nagar, S., Ribshtein, I., Shkoda, I., Perk, S., and Garcia, M. (2009). which forms a complex with the non-glycosylated UL10 gene product.
Detection of wild- and vaccine-type avian infectious laryngotracheitis Virus Res. 112, 108–114.
virus in clinical samples and feather shafts of commercial chickens. Avian Fuchs, W., Ziemann, K., Teifke, J.P., Werner, O., and Mettenleiter, T.C. (2000).
Dis. 53, 618–623. https://doi.org/10.1637/8668-022709-ResNote.1 The non-essential UL50 gene of avian infectious laryngotracheitis virus
Davidson, I., Raibshtein, I., Altori, A., and Elkin, N. (2016). Infectious encodes a functional dUTPase which is not a virulence factor. J. Gen.
laryngotracheitis virus (ILTV) vaccine intake evaluation by detection of Virol. 81, 627–638.
virus amplification in feather pulps of vaccinated chickens. Vaccine 34, Fuchs, W., Wiesner, D., Veits, J., Teifke, J.P., and Mettenleiter, T.C. (2005).
1630–1633. In vitro and in vivo relevance of infectious laryngotracheitis virus gJ
Davidson, I., Natour-Altory, A., Raibstein, I., Kin, E., Dahan, Y., Krispin, H., proteins that are expressed from spliced and nonspliced mRNAs. J. Virol.
and Elkin, N. (2018). Monitoring the uptake of live avian vaccines by 79, 705–716.
their detection in feathers. Vaccine 36, 637–643. Fuchs, W., Granzow, H., Veits, J., and Mettenleiter, T.C. (2012). Identification
Davison, S., Gingerich, E.N., Casavant, S., and Eckroade, R.J. (2006). Evaluation and functional analysis of the small membrane-associated protein pUL11
of the efficacy of a live fowlpox-vectored infectious laryngotracheitis/ of avian infectious laryngotracheitis virus. Virus Res. 163, 599–608.
avian encephalomyelitis vaccine against ILT viral challenge. Avian Dis. https://doi.org/10.1016/j.virusres.2011.12.014
50, 50–54. https://doi.org/10.1637/7398-062105R.1 Fulton, R.M., Schrader, D.L., and Will, M. (2000). Effect of route of
Devlin, J.M., Browning, G.F., and Gilkerson, J.R. (2006a). A glycoprotein vaccination on the prevention of infectious laryngotracheitis in
I- and glycoprotein E-deficient mutant of infectious laryngotracheitis commercial egg-laying chickens. Avian Dis. 44, 8–16.
virus exhibits impaired cell-to-cell spread in cultured cells. Arch. Virol. Gandon, S., Mackinnon, M.J., Nee, S., and Read, A.F. (2001). Imperfect
151, 1281–1289. https://doi.org/10.1007/s00705-005-0721-8 vaccines and the evolution of pathogen virulence. Nature 414, 751–756.
Devlin, J.M., Browning, G.F., Hartley, C.A., Kirkpatrick, N.C., Mahmoudian, https://doi.org/10.1038/414751a
A., Noormohammadi, A.H., and Gilkerson, J.R. (2006b). Glycoprotein García, M. (2017). Current and future vaccines and vaccination strategies
G is a virulence factor in infectious laryngotracheitis virus. J. Gen. Virol. against infectious laryngotracheitis (ILT) respiratory disease of poultry.
87, 2839–2847. Vet. Microbiol. 206, 157–162.
Devlin, J.M., Browning, G.F., Hartley, C.A., and Gilkerson, J.R. (2007). García, M., Spatz, S., and Guy, J.S. (2013a). Infectious laryngotracheitis. In
Glycoprotein G deficient infectious laryngotracheitis virus is a candidate Diseases of Poultry, D.E. Swayne, J.R. Glisson, L.R. McDougald, L.K.
attenuated vaccine. Vaccine 25, 3561–3566. Nolan, D.L. Suarez, and V. Nair, eds (Wiley-Blackwell, Ames, IA), pp.
Devlin, J.M., Browning, G.F., Gilkerson, J.R., Fenton, S.P., and Hartley, 161–179.
C.A. (2008). Comparison of the safety and protective efficacy of García, M., Volkening, J., Riblet, S., and Spatz, S. (2013b). Genomic sequence
vaccination with glycoprotein-G-deficient infectious laryngotracheitis analysis of the United States infectious laryngotracheitis vaccine strains
virus delivered via eye-drop, drinking water or aerosol. Avian Pathol. 37, chicken embryo origin (CEO) and tissue culture origin (TCO). Virology
83–88. 440, 64–74. https://doi.org/10.1016/j.virol.2013.02.007
Devlin, J.M., Viejo-Borbolla, A., Browning, G.F., Noormohammadi, A.H., García, M., Spatz, S.J., Cheng, Y., Riblet, S.M., Volkening, J.D., and
Gilkerson, J.R., Alcami, A., and Hartley, C.A. (2010). Evaluation of Schneiders, G.H. (2016). Attenuation and protection efficacy of ORF C
immunological responses to a glycoprotein G deficient candidate vaccine gene-deleted recombinant of infectious laryngotracheitis virus. J. Gen.
strain of infectious laryngotracheitis virus. Vaccine 28, 1325–1332. Virol. 97, 2352–2362. https://doi.org/10.1099/jgv.0.000521
https://doi.org/10.1016/j.vaccine.2009.11.013 Gimeno, I.M., Cortes, A.L., Guy, J.S., Turpin, E., and Williams, C. (2011).
Devlin, J.M., Vaz, P.K., Coppo, M.J., and Browning, G.F. (2016). Impacts of Replication of recombinant herpesvirus of turkey expressing genes of
poultry vaccination on viruses of wild bird. Curr. Opin. Virol. 19, 23–29. infectious laryngotracheitis virus in specific pathogen free and broiler
https://doi.org/10.1016/j.coviro.2016.06.007 chickens following in ovo and subcutaneous vaccination. Avian Pathol.
Eisenberg, R.J., Ponce de Leon, M., Friedman, H.M., Fries, L.F., Frank, 40, 395–403. https://doi.org/10.1080/03079457.2011.588196
M.M., Hastings, J.C., and Cohen, G.H. (1987). Complement component Gimeno, I.M., Cortes, A.L., Faiz, N.M., Hernandez-Ortiz, B.A., Guy, J.S.,
C3b binds directly to purified glycoprotein C of herpes simplex virus Hunt, H.D., and Silva, R.F. (2015). Evaluation of the protection efficacy
types 1 and 2. Microb. Pathog. 3, 423–435. of a serotype 1 Marek’s disease virus-vectored bivalent vaccine against
Fahey, K.J., and York, J.J. (1990). The role of mucosal antibody in immunity infectious laryngotracheitis and Marek’s disease. Avian Dis. 59, 255–262.
to infectious laryngotracheitis virus in chickens. J. Gen. Virol. 71, 2401– https://doi.org/10.1637/10966-103014-Reg
2405. https://doi.org/10.1099/0022-1317-71-10-2401 Godoy, A., Icard, A., Martinez, M., Mashchenko, A., García, M., and
Fahey, K.J., Bagust, T.J., and York, J.J. (1983). Laryngotracheitis herpesvirus El-Attrachea, J. (2013). Detection of infectious laryngotracheitis virus
infection in the chicken: the role of humoral antibody in immunity to a antibodies by glycoprotein-specific ELISAs in chickens vaccinated with
graded challenge infection. Avian Pathol. 12, 505–514. viral vector vaccines. Avian Dis. 57 (Suppl. 2), 432–436. https://doi.
Fahey, K.J., York, J.J., and Bagust, T.J. (1984). Laryngotracheitis herpesvirus org/10.1637/10345-090312-Reg.1
infection in the chicken. II. The adoptive transfer of resistance with Granzow, H., Klupp, B.G., Fuchs, W., Veits, J., Osterrieder, N., and
immune spleen cells. Avian Pathol. 13, 265–275. Mettenleiter, T.C. (2001). Egress of alphaherpesviruses: comparative
Faiz, N.M., Cortes, A.L., Guy, J.S., Fletcher, O.J., West, M., Montiel, E., and ultrastructural study. J. Virol. 75, 3675–3684. https://doi.org/10.1128/
Gimeno, I.M. (2016). Early infection with Marek’s disease virus can JVI.75.8.3675-3684.2001
jeopardize protection conferred by laryngotracheitis vaccines: a method Guo, H., Kaiser, W.J., and Mocarski, E.S. (2015). Manipulation of apoptosis
to study MDV-induced immunosuppression. Avian Pathol. 45, 606–615. and necroptosis signaling by herpesviruses. Med. Microbiol. Immunol.
Fries, L.F., Friedman, H.M., Cohen, G.H., Eisenberg, R.J., Hammer, C.H., 204, 439–448. https://doi.org/10.1007/s00430-015-0410-5
and Frank, M.M. (1986). Glycoprotein C of herpes simplex virus 1 is Guo, P., Scholz, E., Turek, J., Nodgreen, R., and Maloney, B. (1993).
an inhibitor of the complement cascade. J. Immunol. 137, 1636–1641. Assembly pathway of avian infectious laryngotracheitis virus. Am. J. Vet.
Fuchs, W., and Mettenleiter, T.C. (1996). DNA sequence and Res. 54, 2031–2039.
transcriptional analysis of the UL1 to UL5 gene cluster of infectious Guy, J.S., Barnes, H.J., and Morgan, L.M. (1990). Virulence of infectious
laryngotracheitis virus. J. Gen. Virol. 77, 2221–2229. https://doi. laryngotracheitis viruses: comparison of modified-live vaccine viruses
org/10.1099/0022-1317-77-9-2221 and North Carolina field isolates. Avian Dis. 34, 106–113.